ARTICLE | Clinical News
AUT00206: Additional Ph Ia data
January 20, 2017 9:32 PM UTC
Data from 32 evaluable healthy volunteers in a double-blind, placebo-controlled, U.K. Phase Ia trial showed that oral AUT00206 significantly reduced Mismatch Negativity (MMN) latency at 8 hours post-d...
BCIQ Company Profiles
BCIQ Target Profiles